Keyphrases
18F-THK5351
13%
Alzheimer's Disease
67%
Alzheimer's Disease Classification
7%
Alzheimer's Disease Diagnosis
5%
Alzheimer's Disease Pathology
8%
Alzheimer's Disease Patient
7%
Amnestic Mild Cognitive Impairment (aMCI)
13%
Amyloid Accumulation
5%
Amyloid beta
9%
Amyloid Deposition
9%
Amyloid PET
6%
Amyloid Status
7%
Autosomal Dominant Alzheimer's Disease
14%
Brain Regions
5%
Cerebrospinal Fluid
9%
Cognitive Decline
5%
Cognitive Impairment
5%
Cortical Thickness
12%
Cortical Thinning
11%
Dementia
7%
Dementia Diseases
6%
Disease Course
5%
Disease Pathophysiology
5%
Disease Progression
5%
Early Alzheimer's Disease
5%
Frontotemporal Dementia
11%
Imaging Biomarkers
7%
Induced Pluripotent Stem Cells (iPSCs)
6%
Korean Patients
8%
Mild Cognitive Impairment
17%
Mutation Carriers
5%
Neurodegeneration
6%
Positron Emission Tomography
9%
Sporadic Alzheimer's Disease
7%
Standardized Uptake Value
6%
Symptom Onset
8%
Tau Pathology
5%
Vascular Cognitive Impairment
6%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
47%
Beta Amyloid
9%
Cognitive Disorders
13%
Fluorine-18
15%
Frontotemporal Dementia
6%
Gray Matter
7%
Magnetic Resonance Imaging
8%
Magnetic Resonance Imaging
7%
Mild Cognitive Impairment
30%
Neurodegeneration
7%
Parkinson's Disease
5%
Positron Emission Tomography
16%
Positron Emission Tomography
15%
Stem Cell
6%
Medicine and Dentistry
Alzheimer's Disease
44%
Amyloid Protein
23%
Autosomal Dominant Inheritance
13%
Biological Marker
10%
Cerebrospinal Fluid
9%
Fluorine-18
11%
Magnetic Resonance Imaging
6%
Mild Cognitive Impairment
14%
Pathophysiology
5%
Polyethylene Terephthalate
10%
Positron Emission Tomography
10%
Standardized Uptake Value
5%
Tau
18%